- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jagsonpal Pharmaceuticals Limited — Board Meeting, 29-07-2026: Outcome of Board Meeting
29-07-2026 | 05:09 pm
29-07-2026 | 05:09 pm
Jagsonpal Pharma's board approved Q1 FY27 financial results: Revenue Rs 82.23 Cr, Net Profit Rs 13.19 Cr (EPS Rs 2.00). The company undertook a Rs 40 Cr share buyback and is acquiring an 85% stake in Aequitas Healthcare for Rs 20.8 Cr.
No comments yet. Be the first to comment!